Trial: 202104110

A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus
Nivolumab Versus Standard Chemotherapy in Patients with Previously
Treated Non-Squamous NSCLC

Phase

II

Principal Investigator

Morgensztern, Daniel

Disease Site

Lung

Learn more about this study at: clinicaltrials.gov